PRESS RELEASE published on 02/23/2026 at 15:25, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.07% interest in JTC plc. Position disclosure made under Rule 8.3 of the Takeover Code on 20 February 2026 Position Disclosure The Vanguard Group Rule 8.3 Takeover Code JTC Plc
PRESS RELEASE published on 02/23/2026 at 15:24, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Bluefield Solar Income Fund Limited The Vanguard Group, Inc. discloses a 1.24% stake in Bluefield Solar Income Fund. Form 8.3 revealing position held on 20 February 2026 Form 8.3 Position Disclosure Vanguard Group Stake Disclosure Bluefield Solar Income Fund
PRESS RELEASE published on 02/23/2026 at 15:23, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses 5.03% ownership in Beazley plc with 30,156,894 securities purchased at 12.19 GBP per unit on 20 Feb 2026 The Vanguard Group, Inc. Ownership Disclosure Securities Purchase Beazley Plc GBP 12.19
PRESS RELEASE published on 02/23/2026 at 15:21, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Schroders plc The Vanguard Group, Inc. files Form 8.3 disclosing 2.51% ownership in Schroders plc on 20 Feb 2026. Purchase of 16,023 20p ordinary shares at 5.86 GBP per unit Form 8.3 Schroders Plc Vanguard Group Ownership Disclosure Share Purchase
PRESS RELEASE published on 02/23/2026 at 15:20, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.60% stake in Spire Healthcare Group plc as of 20 February 2026 through Form 8.3 filing Form 8.3 Disclosure Vanguard Group Spire Healthcare Stake
PRESS RELEASE published on 02/23/2026 at 15:20, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Oxford Biomedica plc The Vanguard Group, Inc. discloses 1% ownership of Oxford Biomedica plc securities as of 20th Feb 2026. Details in Form 8.3 filing Form 8.3 Vanguard Group Ownership Disclosure Financial Securities Oxford Biomedica
PRESS RELEASE published on 02/23/2026 at 15:19, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses ownership of 4.92% in Just Group plc's 10p ordinary securities. Form 8.3 filed under Takeover Code Rule 8.3 The Vanguard Group, Inc. Form 8.3 Takeover Code Ownership Disclosure Just Group Plc
PRESS RELEASE published on 02/23/2026 at 15:18, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: LondonMetric Property plc The Vanguard Group, Inc. discloses a 5.29% stake in LondonMetric Property plc. Positions and dealings detailed as per Form 8.3 disclosure requirements LondonMetric Property Plc The Vanguard Group Financial Holdings Form 8.3 Disclosure Stock Transactions
PRESS RELEASE published on 02/23/2026 at 15:17, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses holding 1.12% of International Personal Finance plc's securities. Form 8.3 filed on 23-Feb-2026 Form 8.3 Securities Disclosure Vanguard Group Financial Holdings International Personal Finance Plc
PRESS RELEASE published on 02/23/2026 at 15:17, 6 months 3 days ago Form 8.3 - The Vanguard Group, Inc.: NCC Group plc The Vanguard Group, Inc. discloses holding 4.82% stake in NCC Group plc as of 20th Feb 2026. Sale of 1p ordinary shares at 1.33 GBP per unit The Vanguard Group, Inc. Financial Disclosure Stake Disclosure Share Sale NCC Group Plc
Published on 08/26/2026 at 20:35, 33 minutes ago RUM Reports Quarterly Financial Results for June 30, 2026
Published on 08/26/2026 at 17:40, 3 hours 28 minutes ago Camino Closes $5.8 Million Brokered Private Placement of Units and Concurrent $9.4 Million Non-Brokered Private Placement of Convertible Debentures
Published on 08/26/2026 at 15:25, 5 hours 43 minutes ago CF Energy Announces Financial Results for the Three-Month and Six-Month Periods Ended June 30, 2026
Published on 08/26/2026 at 15:00, 6 hours 8 minutes ago Commercial Launch Initiated for Neonorm Dog, Jaguar Health's Non-Prescription Product for Support of Normal Stool Consistency and GI Fluid Balance in Dogs
Published on 08/26/2026 at 15:00, 6 hours 8 minutes ago Arcus Announces Voting Results of the Annual General and Special Meeting
Published on 08/26/2026 at 18:44, 2 hours 24 minutes ago AUSTRIACARD HOLDINGS AG: Press Release H1 2026 Financial Results
Published on 08/26/2026 at 18:40, 2 hours 28 minutes ago MBC GROUP REVEALS MBC GAMES STUDIO WITH DEBUT TITLE UNVEILING AT GAMESCOM
Published on 08/26/2026 at 18:30, 2 hours 38 minutes ago Heidelberg Pharma AG and Huadong Medicine Receive NMPA Approval for Clinical Trial of HDP-101 Combination Therapy in China
Published on 08/26/2026 at 18:00, 3 hours 8 minutes ago MHM Corporate: reduces the nominal value of its shares to €0.011
Published on 08/26/2026 at 17:45, 3 hours 23 minutes ago LIGHTON: Information concerning the total number of voting rights and shares in the share capital as of 31 July 2026.
Published on 08/26/2026 at 18:02, 3 hours 6 minutes ago Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:00, 3 hours 8 minutes ago Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/25/2026 at 17:45, 1 day 3 hours ago CEGEDIM: DISCLOSURE OF SHARE CAPITAL AND VOTING RIGHTS
Published on 08/25/2026 at 17:45, 1 day 3 hours ago Imerys-08-2026-information-share-capital-and-voting-rights-as-of-31-July-2026
